Extrathoracic Sarcoidosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-02-07
Clinical Trial Update: Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES) [Phase 3]
Phase 3 trial update evaluating a remission-induction regimen with infliximab for severe extrathoracic sarcoidosis has completed.